Quipt Net Income Per E B T from 2010 to 2026
| QIPT Stock | 4.97 0.02 0.40% |
Net Income Per E B T | First Reported 2010-12-31 | Previous Quarter 0.67 | Current Value 0.7 | Quarterly Volatility 1.25415791 |
Macro event markers
Financial statement trends for Quipt Home provide structured context on operating performance and capital structure. The series highlights drivers like Depreciation And Amortization of 62.7 M, Ebitda of 58.3 M or Income Tax Expense of 318.5 K and ratios such as Price To Sales Ratio of 0.7, Dividend Yield of 0.0 or PTB Ratio of 1.62, complementing Quipt Home Valuation and Volatility.
Quipt | Net Income Per E B T |
Evaluating Quipt Home's Net Income Per E B T across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Quipt Home Medical's fundamental strength.
Latest Quipt Home's Net Income Per E B T Growth Pattern
Below is the plot of the Net Income Per E B T of Quipt Home Medical over the last few years. It is Quipt Home's Net Income Per E B T historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Quipt Home's overall financial position and show how it may be relating to other accounts over time.
| Net Income Per E B T | 10 Years Trend |
|
Net Income Per E B T |
| Timeline |
Quipt Net Income Per E B T Regression Statistics
| Arithmetic Mean | 1.03 | |
| Coefficient Of Variation | 122.23 | |
| Mean Deviation | 0.61 | |
| Median | 0.94 | |
| Standard Deviation | 1.25 | |
| Sample Variance | 1.57 | |
| Range | 6.7781 | |
| R-Value | -0.34 | |
| Mean Square Error | 1.49 | |
| R-Squared | 0.11 | |
| Significance | 0.19 | |
| Slope | -0.08 | |
| Total Sum of Squares | 25.17 |
Quipt Net Income Per E B T History
Stock Overview, Methodology & Data Sources
Quipt Home is accessible through the Toronto Exchange marketplace. This stock section frames Quipt Home within its peer set and highlights how fundamentals align with price behavior. Current metrics include P/B of 1.6, profit margin of -4.03%. Quipt Home has a market cap of 220.1 M, ROE of -9.31%.
Methodology
Unless otherwise specified, financial data for Quipt Home Medical is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Quipt (CA:QIPT) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: This report references public filings and market reference sources and institutional disclosures, including U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Food & Drug Administration (FDA). Certain datasets may update with delay depending on source availability. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.
Analyst Sources
Quipt Home Medical may have analyst coverage included in Macroaxis-derived consensus inputs when available. Updates may occur throughout the day.
This content is curated and reviewed by:
Raphi Shpitalnik - Junior Member of Macroaxis Editorial BoardPair Trading with Quipt Home
Pair trading with Quipt Home can help investors hedge some company-specific exposure by balancing a long view with an offsetting position. The key question is whether the second leg adds real hedge value instead of just creating a more complex version of the same risk.
Moving against Quipt Stock
| 0.53 | AAPL | Apple CDR | PairCorr |
| 0.53 | AAPL | Apple Inc CDR | PairCorr |
| 0.45 | ZAAP | APPLE BMO CDR | PairCorr |
| 0.4 | MSFT | Microsoft CDR | PairCorr |
| 0.4 | MSFT | Microsoft Corp CDR | PairCorr |
Sophisticated investors use correlation analysis to build Quipt Home replacement strategies that go beyond simple sector matching. Assets with similar factor exposures to Quipt Home Medical provide the most accurate portfolio substitution during tax-loss harvesting periods.
Statistical correlation between Quipt Home and its peers is an essential input for mean-variance portfolio optimization. Lower correlation of Quipt Home Medical with other holdings allows for a more efficient frontier with superior risk-adjusted returns.
Correlation analysis and pair evaluation for Quipt Home can support hedging context. This approach is commonly reviewed within sectors and across broader groups.More Resources for Quipt Stock Analysis
A comprehensive view of Quipt Home Medical starts with financial statements and ratio context. Ratios and trend metrics help frame Quipt Home's operating context. Highlighted below are reports that provide context for Quipt Home Medical Stock:Quipt Home Correlation provides competitor comparison context for Quipt Home. This supports competitive context. Analysis related to Quipt Home should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.